Pulmonary tuberculosis in immunocompetent : causes and consequenses

##plugins.themes.academic_pro.article.sidebar##

Published Dec 11, 2015
Download
pdf
Vol. 93 No. 8 (2015): Issue Aug 2015

##plugins.themes.academic_pro.article.main##

Sonia Ben Nasr
Nawel Chaouch
Sawssen Bacha
Sana Cheikh Rouhou
Hajer Racil
Mourad Zarrouk
Abdellatif Chabbou

Abstract

SUMMARY
Background: Despite scientific advances, extended forms of pulmonary tuberculosis are still relevant. The aim of our study was to determine clinical features and outcome of extended pulmonary tuberculosis in immunocompetent patients.
Methods: Retrospective comparative study including 100 patients HIV negative, presenting pulmonary tuberculosis divided into 2 groups of 50 patients (group1: extended tuberculosis and group2: localized tuberculosis). Tuberculosis was considered extended when reaching above one lobe.
Results: The average age was comparable in the 2 groups (p = 0.138). In group1, we noted a higher incidence of diabetes (p = 0.037) and malnutrition (p = 0.045). Clinically, patients in group1 had more general signs (p=0.033) and dyspnoea (p=0.037). Biologically, anemia (p<0.001), leukocytosis (p=0.05), elevated CRP (p=0.031), thrombocytosis (p=0.023), hyponatremia (p = 0.001) and liver disturbances (p = 0.001) were significantly more frequent in group1. Concerning the evolution, time to smear negativity was significantly longer (p=0.012). Similarly, radiological sequelae were more frequent (p = 0.02) and more extensive (p = 0.012). Positive predictive value of radiological extent in disease evolution was 62% with a confidence interval between 47.2% and 75%.
Conclusions: The extent of pulmonary tuberculosis is an important factor in clinical and biological presentation and disease evolution. Indeed, patients with extended tuberculosis develop more severe presentation and are more likely to develop parenchymal sequelae.

Keywords:

Pulmonary tuberculosis - radiology - biology - evolution - prognosis

##plugins.themes.academic_pro.article.details##

References

  1. Rapport OMS 2012 sur la lutte contre la tuberculose dans le monde.
  2. Picon PD, Bassanesi SL, Avancini Caramori ML et al. Risk factors for recurrence of tuberculosis. J Bras Pneumol 2007; 33 :572-8.
  3. Yeung MC, Noertjojo K, S. Chan SL et al. Sex differences in tuberculosis in Hong Kong. Int J Tuberc Lung Dis 2002; 6:11-18.
  4. Siawaya JFD, Bapela NB, Ronacher K et al. Immune parameters as markers of tuberculosis extent of disease and early prediction of antituberculosis chemotherapy response. J Infect 2008; 56: 340-7.
  5. Mboussa J, Monabeka H, Kombo M et al. Evolution de la tuberculose pulmonaire chez les diabétiques. Rev Pneumol Clin 2003 ; 59 : 39-44.
  6. Sidibé EH. Diabète et tuberculose pulmonaire aspects épidémiologiques, physiopathologiques et symptomatologiques. Sante 2007 ;17 : 29-32.
  7. Onwubalili JK, Scott GM. Immune status in tuberculosis and response to treatment. Tubercule 1988;69: 81-94.
  8. Kuaban C , Koulla-shiro S , Hagbe P. Caracteristiques des patients adultes morts de tuberculose pulmonaire active a Yaounde-Cameroun. Med Afr Noire 1997 ; 44 :345-9.
  9. Kaltenbach G, Grunenberger F, Schlienger JL et al. Effets de l'âge sur la présentation et le pronostic de la tuberculose en médecine interne. Presse Med 2000 ; 30:1446-9.
  10. Chan CHS, Woo J, Or KKH et al. The effect of age on the presentation of patients with tuberculosis. Tuber Lung Dis 1995; 76: 290-4.
  11. May T, Bevilacqua S. Aspects cliniques actuels de la tuberculose. EMC Radiol 2005; 2 : 116-20.
  12. Fiske CT, Hamilton CD, Stout JE. Alcohol use and clinical manifestations of tuberculosis. J Infect 2009; 58: 395-401.
  13. Lorent N, Mugwaneza P, Mugabekazi J et al. Risk factors for delay in the diagnosis and treatment of tuberculosis at a referral hospital in Rwanda. Int J Tuberc Lung Dis 2008; 12: 392-6.
  14. Golub JE, Bur S, Cronin WA et al. Patient and health care system delays in pulmonary tuberculosis diagnosis in a low-incidence state. Int J Tuberc Lung Dis 2005 9:992-8.
  15. Diez M, Bleda MJ, Alcaide J. Determinants of health system delay among confirmed tuberculosis cases in Spain. Eur J Public Health 2005; 15; 343-9.
  16. Breen RAM, Leonard O, Perrin FMR et al. How good are systemic symptoms and blood inflammatory markers at detecting individuals with tuberculosis?. Int J Tuberc Lung Dis 2008; 12: 44-9.
  17. Min Jae K, Hye-Ryoun K, Seung Sik H et al. Prevalence and its predictors of extrapulmonary involvement in patients with pulmonary tuberculosis. J Korean Med Sci 2009; 24: 237-41.
  18. Deniz O, Tozkoparan E, Yonem A et al. Low parathormone levels and hypercalcaemia in patients with pulmonary tuberculosis: relation to radiological extent of disease and tuberculin skin test. Int J Tuberc Lung Dis 2005; 9:317-21.
  19. Walzl G, Ronacher K, Siawaya JFD et al. Biomarkers for TB treatment response: Challenges and future strategies. J Infect 2008; 57: 103-9.
  20. Turken O, Kunter E, Sezer M et al. Hemostatic changes in active pulmonary tuberculosis. Int J Tuberc Lung Dis 2002; 6: 927-32.
  21. Al Jarad N, Parastatides S, Paul EA et al. Characteristics of patients with drug resistant and drug sensitive tuberculosis in East London between 1984 and 1992. Thorax 1994;49:808-10.
  22. Ruddy M, Balabanova Y, Graham C. Rates of drug resistance and risk factor analysis in civilian and prison patients with tuberculosis in Samara Region, Russia. Thorax 2005;60:130-5.
  23. Pande JN, Singh SPN, Khilnani GC et al. Risk factors for hepatotoxicity from antituberculosis drugs: a case-control study. Thorax 1996;51:132-6.
  24. Young HE, Ju CE, Hoon LC. Radiographic improvement and its predictors in patients with pulmonary tuberculosis. Int J Infect Dis 2009: 1-6.
  25. Hnizdo E, Singh T, Churchyard G. Chronic pulmonary function impairment caused by initial and recurrent pulmonary tuberculosis following treatment. Thorax 2000; 55: 32-8.
  26. Sacks LV, Pendle S. Factors related to in-hospital deaths in patients with tuberculosis. Arch Intern Med 1998; 158: 1916-22.
  27. Mathew TA, Ovsyanikova TN, Shin SS et al. Causes of death during tuberculosis treatment in Tomsk Oblast, Russia. Int J Tuberc Lung Dis 2006; 10: 857-63.
  28. Segarra F, Sherman DS. Relapses in Pulmonary Tuberculosis. Dis Chest 1967;51:59-63.
  29. J.-P. Sénac. Tuberculose du sujet immunodéprimé. Rev Mal Respir 2008 ; 25 : 55-56.
  30. Arshi Munawwar, Sarman Singh. AIDS associated tuberculosis: A catastrophic collision to evade the host immune system. Tuberculosis 2012 ;92 : 384-7.